tradingkey.logo
tradingkey.logo
Search

Bioharvest Sciences Inc

BHST
Add to Watchlist
2.910USD
+0.050+1.75%
Close 07/01, 16:00ETQuotes delayed by 15 min
64.98MMarket Cap
LossP/E TTM

Bioharvest Sciences Inc

2.910
+0.050+1.75%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+1.75%

5 Days

0.00%

1 Month

-21.35%

6 Months

-43.93%

Year to Date

-43.93%

1 Year

-57.62%

Key Figures
2.910Open
2.975High
61.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.27%Turnover Ratio
2.860Prev. Close
2.900Low
177.47KTurnover
LossP/E Static
2.87P/B
0.00%Div Yield TTM
-31.71%ROA
12.30052wk High
1.83Volume Ratio
-12.91MNet Profit
22.67MShares
-0.5864EPS TTM
-8.58Beta
-103.29%ROE
3.16052wk Low
2.62%Amplitude
59.21%Gross Margin
64.98MMarket Cap
-4.52Reward/Risk
4.64%Risk Rate

Key Insights

Bioharvest Sciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 48 out of 93 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.75.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bioharvest Sciences Inc's Score

Industry at a Glance

Industry Ranking
48 / 93
Overall Ranking
240 / 4564
Industry
Food & Tobacco

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Bioharvest Sciences Inc Highlights

StrengthsRisks
BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 172.32% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 34.51M.
Overvalued
The company’s latest PE is -4.96, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.80M shares, increasing 47.82% quarter-over-quarter.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
12.750
Target Price
+345.80%
Upside Space

Bioharvest Sciences Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bioharvest Sciences Inc Info

BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Ticker SymbolBHST
CompanyBioharvest Sciences Inc
CEOSobel (Ilan)
Websitehttps://bioharvest.com/about/

FAQs

What is the current price of Bioharvest Sciences Inc (BHST)?

The current price of Bioharvest Sciences Inc (BHST) is 2.91.

What is the symbol of Bioharvest Sciences Inc?

The ticker symbol of Bioharvest Sciences Inc is BHST.

What is the 52-week high of Bioharvest Sciences Inc?

The 52-week high of Bioharvest Sciences Inc is 12.30.

What is the 52-week low of Bioharvest Sciences Inc?

The 52-week low of Bioharvest Sciences Inc is 3.16.

What is the market capitalization of Bioharvest Sciences Inc?

The market capitalization of Bioharvest Sciences Inc is 64.98M.

Is Bioharvest Sciences Inc (BHST) currently rated as Buy, Hold, or Sell?

According to analysts, Bioharvest Sciences Inc (BHST) has an overall rating of Buy, with a price target of 12.75.

What is the Earnings Per Share (EPS TTM) of Bioharvest Sciences Inc (BHST)?

The Earnings Per Share (EPS TTM) of Bioharvest Sciences Inc (BHST) is -0.60.